Y-mAbs Therapeutics Inc (YMAB)
17.22
+0.07
(+0.41%)
USD |
NASDAQ |
May 06, 16:00
17.22
0.00 (0.00%)
After-Hours: 20:00
Y-mAbs Therapeutics Price to Book Value: 7.481 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 7.451 |
| May 02, 2024 | 7.494 |
| May 01, 2024 | 7.164 |
| April 30, 2024 | 6.608 |
| April 29, 2024 | 6.734 |
| April 26, 2024 | 6.391 |
| April 25, 2024 | 6.447 |
| April 24, 2024 | 6.643 |
| April 23, 2024 | 6.664 |
| April 22, 2024 | 6.586 |
| April 19, 2024 | 6.573 |
| April 18, 2024 | 6.502 |
| April 17, 2024 | 6.550 |
| April 16, 2024 | 6.563 |
| April 15, 2024 | 6.464 |
| April 12, 2024 | 6.229 |
| April 11, 2024 | 6.342 |
| April 10, 2024 | 5.978 |
| April 09, 2024 | 6.099 |
| April 08, 2024 | 6.264 |
| April 05, 2024 | 6.268 |
| April 04, 2024 | 6.312 |
| April 03, 2024 | 6.251 |
| April 02, 2024 | 6.398 |
| April 01, 2024 | 7.018 |
| Date | Value |
|---|---|
| March 28, 2024 | 7.049 |
| March 27, 2024 | 7.153 |
| March 26, 2024 | 6.806 |
| March 25, 2024 | 6.810 |
| March 22, 2024 | 7.036 |
| March 21, 2024 | 7.344 |
| March 20, 2024 | 6.715 |
| March 19, 2024 | 6.455 |
| March 18, 2024 | 5.965 |
| March 15, 2024 | 6.372 |
| March 14, 2024 | 6.502 |
| March 13, 2024 | 6.867 |
| March 12, 2024 | 6.975 |
| March 11, 2024 | 7.148 |
| March 08, 2024 | 7.638 |
| March 07, 2024 | 7.647 |
| March 06, 2024 | 7.799 |
| March 05, 2024 | 7.214 |
| March 04, 2024 | 7.513 |
| March 01, 2024 | 8.102 |
| February 29, 2024 | 7.240 |
| February 28, 2024 | 7.079 |
| February 27, 2024 | 7.153 |
| February 26, 2024 | 7.153 |
| February 23, 2024 | 7.157 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.132
Minimum
Mar 22 2023
19.98
Maximum
Jan 11 2021
6.529
Average
5.717
Median
Oct 08 2021
Price to Book Value Benchmarks
| The Cooper Companies Inc | 2.388 |
| Puma Biotechnology Inc | 4.158 |
| Humacyte Inc | 39.96 |
| Moderna Inc | 3.651 |
| NovaBay Pharmaceuticals Inc | 2.017 |
Price to Book Value Related Metrics
| PS Ratio | 8.861 |
| Price | 17.22 |
| Earnings Yield | -2.85% |
| Market Cap | 755.49M |